Your browser doesn't support javascript.
loading
Diagnostic utility of 11 C-methionine PET/CT in primary hyperparathyroidism in a UK cohort: A single-centre experience and literature review.
Huynh, Kevin A; MacFarlane, James; Newman, Christine; Gillett, Daniel; Das, Tilak; Scoffings, Daniel; Cheow, Heok K; Moyle, Penelope; Koulouri, Olympia; Harper, Ines; Aloj, Luigi; Mendichovszky, Iosif A; Inchiappa, Danilo; Buch, Harit N; Chung, Teng-Teng; Simpson, Helen L; Powlson, Andrew S; Challis, Ben G; Bashari, Waiel A; Stokes, Victoria J; Masterson, Liam; Jani, Piyush; Fish, Brian; Gurnell, Mark; Casey, Ruth T.
Afiliação
  • Huynh KA; Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
  • MacFarlane J; Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
  • Newman C; Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
  • Gillett D; Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
  • Das T; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Scoffings D; Department of Radiology, University of Cambridge, Cambridge, UK.
  • Cheow HK; Department of Radiology, University of Cambridge, Cambridge, UK.
  • Moyle P; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Koulouri O; Department of Radiology, University of Cambridge, Cambridge, UK.
  • Harper I; Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
  • Aloj L; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Mendichovszky IA; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Inchiappa D; Department of Radiology, University of Cambridge, Cambridge, UK.
  • Buch HN; Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Chung TT; Department of Radiology, University of Cambridge, Cambridge, UK.
  • Simpson HL; Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
  • Powlson AS; Royal Wolverhampton NHS Trust, Wolverhampton, UK.
  • Challis BG; Department of Endocrinology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Bashari WA; Department of Endocrinology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Stokes VJ; Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
  • Masterson L; Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
  • Jani P; Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
  • Fish B; Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
  • Gurnell M; Department of ENT/Head and Neck Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Casey RT; Department of ENT/Head and Neck Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Clin Endocrinol (Oxf) ; 99(3): 233-245, 2023 09.
Article em En | MEDLINE | ID: mdl-37272391

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias das Paratireoides / Adenoma / Hiperparatireoidismo Primário Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias das Paratireoides / Adenoma / Hiperparatireoidismo Primário Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article